🔎 Trials Near Me

홈 › 다발성 골수종 › 미주리

미주리의 다발성 골수종 임상 시험

다발성 골수종 관련 연구 26개가 미주리 내 여러 지역에서 참여자를 모집하고 있습니다.

미주리의 도시

공식 연구 텍스트(영어)

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

  • Washington University School of Medicine, St Louis
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT04973605

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

  • Washington University School Of Medicine, St Louis
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05201781

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

  • Washington University School Of Medicine, St Louis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04634552

Collection of Tissue Samples for Cancer Research

  • Washington University - St. Louis, St Louis
피험자 모집 중관찰 연구
2 Months · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT00900198

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • Washington University School of Medicine, St Louis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06297226

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

  • Washington University School of Medicine, St Louis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06980480

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

  • Research Site, St Louis
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT07681596

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

  • GSK Investigational Site, Bridgeton
  • GSK Investigational Site, Springfield
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT07227311

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  • American Oncology Partners, P.A. Dba MidAmerica Cancer Care, Belton
  • MIVA Medical, Independence
  • Kansas City VA Medical Center, Kansas City
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT06152575

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • 외 19개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04566328

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

  • Research Site, St Louis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 14. 업데이트됨 · NCT07764978

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance

  • Washington University School of Medicine, St Louis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT06483100

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  • Washington University/Siteman Cancer Center, St Louis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT07284758

Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)

  • Washington University School of Medicine, St Louis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 21. 업데이트됨 · NCT07200089

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

  • Washington University School of Medicine, St Louis
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 7. 14. 업데이트됨 · NCT06340646

Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma

  • Washington University School of Medicine, St Louis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 9. 업데이트됨 · NCT06185751

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Institute, East, Kansas City
  • Saint Luke's Cancer Institute, Kansas City
  • Saint Luke's Cancer Institute, Kansas City North, Kansas City
  • 외 3개
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

64Cu-LLP2A for Imaging Hematologic Malignancies

  • Washington University School of Medicine, St Louis
피험자 모집 중초기 1상건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT06636175

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

  • Saint Louis Cancer and Breast Institute-Ballwin, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • 외 21개
피험자 모집 중3상
전 연령 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT05561387

Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma

  • Washington University School of Medicine, St Louis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 8. 업데이트됨 · NCT07200102

An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers

  • Washington University School of Medicine, St Louis
피험자 모집 중
18세 ~ 99세 · 모든 성별 · 2026. 6. 1. 업데이트됨 · NCT07226934

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

  • Saint Louis University, St Louis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 4. 22. 업데이트됨 · NCT03823534

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

  • Washington University School of Medicine, St Louis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 3. 11. 업데이트됨 · NCT06623630

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.